washington/los angeles u.s. president donald trump meet tuesday pharmaceutical executives call manufacture drug unite state cut price vow speed approval new medicine ease regulation trump tell government pay astronomical price medicine health program old disable poor people say would soon appoint new u.s. food drug administration leader go streamline fda trump say statement refer regulatory agency responsible vet new drug safe effective meet trump pharmaceutical executives signal defuse tensions keep drug stock price check since presidential election share group rally tuesday follow meet even broad stock market slide trump populist else drug price skyrocket comment administration go happen say market strategist quincy crosby prudential financial newark new jersey say trump play balance act control price loosen regulations think majority americans want regulations lift drug makers attend meet top executives merck co inc johnson celgene corp eli lilly co amgen inc switzerland novartis ag nov n.s well head pharmaceutical research manufacturers america phrma lobby group accord transcript televise portion meet amgen chief executive officer robert brad way promise add 1,600 u.s. job california-based biotechnology company year amgen clarify email currently employ around 20,000 people worldwide include 12,000 unite state say 1,600 include new staff well hire address attrition celgene lilly merck amgen say email meet encourage trump focus innovation tax reform need value-driven health care system lilly say discussion topics also include strong trade agreements remove outdated regulations drive cost slow innovation phrma echo point post-meeting statement add policies enact would result 350,000 new job next 10 years tax deregulation things could really help us expand operations lilly ceo dave rick say officials novartis immediately respond request additional comment share six company mostly high overall gain average 0.7 percent compare 0.4 percent drop broad 500. nasdaq biotech index 1.2 percent reverse early losses 500 health care index gain 0.6 percent get price lot reason choice medicare medicaid trump say cite nation government insurance program elderly poor disable trump also say currency devaluation countries increase drugmakers outsource production call company make products unite state foreign countries must pay fair share drug development cost add go end global freeload unite state typically pay drug develop nation western european countries well japan government-run health care coverage drug price negotiate high drug price become national issue past two years healthcare cost rise trump spook pharmaceutical biotech investors say jan. 11 inauguration drug company get away murder charge government medicine would something company executives meanwhile try tread careful line defend industry express optimism unite state would continue reward scientific advance regulations great streamline fda perhaps jack ablin chief investment officer bmo private bank chicago say trump go address constituency drug price come think maybe pyrrhic victory trump push drugmakers low price u.s. production